Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0B1RV
|
||||
| Former ID |
DNC012545
|
||||
| Drug Name |
2-Cyclopentyl-1H-imidazo[4,5-c]quinolin-4-ylamine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530590] | ||
| Formula |
C15H16N4
|
||||
| Canonical SMILES |
C1CCC(C1)C2=NC3=C(N2)C(=NC4=CC=CC=C43)N
|
||||
| InChI |
1S/C15H16N4/c16-14-13-12(10-7-3-4-8-11(10)17-14)18-15(19-13)9-5-1-2-6-9/h3-4,7-9H,1-2,5-6H2,(H2,16,17)(H,18,19)
|
||||
| InChIKey |
KPONPDGMNFNBFA-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Adenosine A2a receptor | Target Info | Inhibitor | [530590] | |
| Adenosine A1 receptor | Target Info | Inhibitor | [530590] | ||
| Adenosine A2b receptor | Target Info | Inhibitor | [530590] | ||
| KEGG Pathway | Rap1 signaling pathway | ||||
| Calcium signaling pathway | |||||
| cAMP signaling pathway | |||||
| Neuroactive ligand-receptor interaction | |||||
| Vascular smooth muscle contraction | |||||
| Parkinson's disease | |||||
| Alcoholismhsa04022:cGMP-PKG signaling pathway | |||||
| Sphingolipid signaling pathway | |||||
| Morphine addictionhsa04015:Rap1 signaling pathway | |||||
| Alcoholism | |||||
| Pathway Interaction Database | HIF-2-alpha transcription factor networkcmyb_pathway:C-MYB transcription factor network | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.